We are live on ! Find out more
IMA

ImageneBio Inc

55 hedge funds and large institutions have $42.7M invested in ImageneBio Inc in 2024 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 15 increasing their positions, 17 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 8

2% more funds holding

Funds holding: 5455 (+1)

4.74% less ownership

Funds ownership: 67.11%62.37% (-4.7%)

12% less repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 17

33% less capital invested

Capital invested by funds: $63.8M → $42.7M (-$21.1M)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
55
Holders Change
+1
Holders Change %
+1.85%
% of All Funds
0.79%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
10
Increased
15
Reduced
17
Closed
8
Calls
Puts
Net Calls
Net Calls Change

IMA Hedge Fund Activity: Q1 2024 in Review

55 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in ImageneBio Inc (IMA) for Q1 2024, worth a combined $42.7M — down 33% from $63.8M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new IMA positions and 8 closed out — a net gain of 2 holders — while 15 added to existing stakes and 17 trimmed.

The largest buyer was Blue Owl Capital Holdings, adding an estimated $2.94M. The largest seller was Fidelity Investments, cutting an estimated $6.34M.

  • 55 institutional investors held ImageneBio Inc (IMA) as of Q1 2024, up from 54 in Q4 2023.
  • Funds reported $42.7M of ImageneBio Inc stock for Q1 2024, down 33% quarter-over-quarter.
  • 10 funds opened new ImageneBio Inc positions in Q1 2024 and 8 closed out, a net change of +2 holders.
  • The largest ImageneBio Inc buyer in Q1 2024 was Blue Owl Capital Holdings, an estimated $2.94M added.
  • The largest ImageneBio Inc seller in Q1 2024 was Fidelity Investments, an estimated $6.34M sold.

Based on aggregated 13F filings for Q1 2024.